COVID-19 Vaccine | Bharat Biotech#39;s Covaxin reported adverse event during Phase 1 trials, trials not halted

The adverse event occurred in a 35-year-old participant with no co-morbidities, who was part of Phase 1 trials. The participant was hospitalised with viral pneumonitis, a couple of days after being administered the vaccine

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-bharat-biotech39s-covaxin-reported-adverse-event-during-phase-1-trials-trials-not-halted_14518241.html